BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38537775)

  • 1. Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer.
    Zhao Z; Cai Z; Zhang S; Yin X; Jiang T; Shen C; Yin Y; Sun H; Chen Z; Han J; Zhang B
    Cancer Lett; 2024 May; 589():216796. PubMed ID: 38537775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiostrepton confers protection against reactive oxygen species-related apoptosis by restraining FOXM1-triggerred development of gastric cancer.
    Liu SX; Zhou Y; Zhao L; Zhou LS; Sun J; Liu GJ; Du YS; Zhou YN
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):385-404. PubMed ID: 36152915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and mechanism of exosome-mediated A FOXM1 related long noncoding RNA in gastric cancer.
    Zhang Y; Chen L; Ye X; Wu Z; Zhang Z; Sun B; Fu H; Fu C; Liang X; Jiang H
    J Nanobiotechnology; 2021 May; 19(1):133. PubMed ID: 33971889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1.
    Xing S; Tian Z; Zheng W; Yang W; Du N; Gu Y; Yin J; Liu H; Jia X; Huang D; Liu W; Deng M
    Mol Cancer; 2021 Jan; 20(1):9. PubMed ID: 33407516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone chaperone ASF1B promotes human β-cell proliferation via recruitment of histone H3.3.
    Paul PK; Rabaglia ME; Wang CY; Stapleton DS; Leng N; Kendziorski C; Lewis PW; Keller MP; Attie AD
    Cell Cycle; 2016 Dec; 15(23):3191-3202. PubMed ID: 27753532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protumor Effects of Histone H3-H4 Chaperone Antisilencing Feature 1B Gene on Lung Adenocarcinoma: In Silico and
    Wu L; Jie B
    Comput Math Methods Med; 2021; 2021():5005459. PubMed ID: 34956399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1.
    Wu J; Qin W; Wang Y; Sadik A; Liu J; Wang Y; Song P; Wang X; Sun K; Zeng J; Wang L
    J Cell Biochem; 2018 Nov; 119(11):9042-9054. PubMed ID: 30076647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing forkhead box M1 promotes apoptosis and autophagy through SIRT7/mTOR/IGF2 pathway in gastric cancer cells.
    Yu W; Cui X; Wan Z; Yu Y; Liu X; Jin L
    J Cell Biochem; 2018 Nov; 119(11):9090-9098. PubMed ID: 29953672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development.
    Zhang Y; Ye X; Chen L; Wu Q; Gao Y; Li Y
    Int J Biol Sci; 2018; 14(5):531-541. PubMed ID: 29805304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
    Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
    Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Forkhead Box M1 Regulates the Proliferation,Invasion,and Drug Resistance of Gastric Cancer Cells
    Ge N; Jiang YY; Pan ZP; Wan J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):713-720. PubMed ID: 37927011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
    Roca MS; Moccia T; Iannelli F; Testa C; Vitagliano C; Minopoli M; Camerlingo R; De Riso G; De Cecio R; Bruzzese F; Conte M; Altucci L; Di Gennaro E; Avallone A; Leone A; Budillon A
    J Exp Clin Cancer Res; 2022 Mar; 41(1):83. PubMed ID: 35241126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of FOXM1 as a specific marker for triple‑negative breast cancer.
    Tan Y; Wang Q; Xie Y; Qiao X; Zhang S; Wang Y; Yang Y; Zhang B
    Int J Oncol; 2019 Jan; 54(1):87-97. PubMed ID: 30365046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer.
    Tang Q; Liu C; Zhang S; He L; Liu Y; Wang J; Zhao X; Li X
    Neoplasia; 2023 Feb; 36():100863. PubMed ID: 36528911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer.
    Hsu CC; Liao WY; Chang KY; Chan TS; Huang PJ; Chiang CT; Shan YS; Cheng LH; Liao TY; Tsai KK
    Gastric Cancer; 2021 May; 24(3):624-639. PubMed ID: 33515163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of EZH2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway.
    Huang B; Mu P; Yu Y; Zhu W; Jiang T; Deng R; Feng G; Wen J; Zhu X; Deng Y
    Gastric Cancer; 2021 Jan; 24(1):72-84. PubMed ID: 32529327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.
    Ito T; Kohashi K; Yamada Y; Maekawa A; Kuda M; Furue M; Oda Y
    Histopathology; 2016 Jul; 69(1):63-71. PubMed ID: 26619071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.
    Jiang L; Wang P; Chen L; Chen H
    Int J Clin Exp Pathol; 2014; 7(9):5450-60. PubMed ID: 25337187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor.
    Shibui Y; Kohashi K; Tamaki A; Kinoshita I; Yamada Y; Yamamoto H; Taguchi T; Oda Y
    J Cancer Res Clin Oncol; 2021 May; 147(5):1499-1518. PubMed ID: 33221995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.